|The US Cooperative Group system is in the process of transitioning to the NCI National Clinical Trials Network (NCTN). The official transition date for many aspects is March 1st 2014. The majority of the transition requirements for Canadian Cancer Trials Group as the Canadian arm of the network are administrative in nature and are being managed by the team at Central Office. For example, we are ensuring that all Canadian Cancer Trials Group Canadian Member Centres receive US State Department Federal Clearance as required by the terms of our NCTN grant. However, the CTSU issued a broadcast on February 14 detailing several key aspects of the transition and we wanted to clarify what this means for Canadian Cancer Trials Group Canadian Member Centres.
As we approach March 1, 2014 and beyond, we will continue to keep Canadian Cancer Trials Group members up to date on transition issues with direct impact. Please do not hesitate to contact our office at email@example.com if you have any questions.
- Registration/Randomization for all US Intergroup studies led by Canadian Cancer Trials Group in Canada will continue to be managed by Central Office. Central Office will facilitate registration/randomization through OPEN as required. Centres should continue to follow standard processes for registration/ randomization for this group of trials.
- As communicated by CTSU on February 14, 2014, service interruptions are expected for multiple CTSU applications during the transition weekend beginning on February 28, 2014 until Monday, March 3, 2014 at 9:00 am EST. OPEN will not be available for patient enrollment from 3 PM EST on 2/28 until 9AM EST on 3/3. Please contact the trial team at Canadian Cancer Trials Group if you have any concerns about timing of any registration/randomization that may be affected by the service interruptions.